STOCK TITAN

BNP Paribas unit reports 0.9% stake in ASP Isotopes

BNP Paribas Asset Management UK Ltd has filed an amended Schedule 13G reporting beneficial ownership of 944,326 shares of ASP Isotopes Inc. common stock, representing 0.9% of the outstanding class as of December 31, 2025.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BNP Paribas Asset Management UK Ltd has filed an amended Schedule 13G reporting beneficial ownership of 944,326 shares of ASP Isotopes Inc. common stock, representing 0.9% of the outstanding class as of December 31, 2025. The firm reports sole voting and dispositive power over all of these shares and confirms they are held in the ordinary course of business, not to change or influence control of ASP Isotopes.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BNP Paribas Asset Management UK Ltd report in this ASPI Schedule 13G/A?

BNP Paribas Asset Management UK Ltd reports beneficial ownership of 944,326 ASP Isotopes common shares, equal to 0.9% of the class. The firm holds sole voting and dispositive power over these shares as of December 31, 2025 under an amended Schedule 13G filing.

How much of ASP Isotopes (ASPI) does BNP Paribas Asset Management own?

BNP Paribas Asset Management UK Ltd beneficially owns 944,326 ASP Isotopes common shares, representing 0.9% of the outstanding class. The position is below the 5% threshold and is reported with sole voting and sole dispositive power over all reported shares.

Is BNP Paribas Asset Management seeking control of ASP Isotopes (ASPI)?

The filing states the ASP Isotopes shares were acquired and are held in the ordinary course of business, not to change or influence control. It also notes the holding is not part of any transaction aimed at influencing control, except for specified proxy nomination activities.

What type of SEC filing is this for ASP Isotopes (ASPI)?

This is an amended Schedule 13G/A, a beneficial ownership report used by certain institutional investors. It discloses that BNP Paribas Asset Management UK Ltd holds 0.9% of ASP Isotopes common stock with sole voting and dispositive power over 944,326 shares.

Who signed the ASP Isotopes (ASPI) Schedule 13G/A for BNP Paribas Asset Management?

The Schedule 13G/A was signed by Timothy Trotter, identified as CCO, US Regulatory Matters, on behalf of BNP Paribas Asset Management UK Ltd. The signature certifies the accuracy and completeness of the beneficial ownership information presented in the report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BNP Paribas Asset Management UK Ltd
Signature:Timothy Trotter
Name/Title:CCO, US Regulatory Matters
Date:02/09/2026

Keep reading